Similar articles

• A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.

  Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J. Pearson TA, et al. Mayo Clin Proc. 2005 May;80(5):587-95. doi: 10.4065/80.5.587. Mayo Clin Proc. 2005. PMID: 15887425 Clinical Trial.
• Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

  Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group. Bennett S, et al. J Womens Health (Larchmt). 2004 Dec;13(10):1101-7. doi: 10.1089/jwh.2004.13.1101. J Womens Health (Larchmt). 2004. PMID: 15650343
• Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

  Daskalopoulou SS, Mikhailidis DP. Daskalopoulou SS, et al. Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
• Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

  Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP. Gazi IF, et al. Curr Med Res Opin. 2007 Sep;23(9):2183-92. doi: 10.1185/030079907X226267. Curr Med Res Opin. 2007. PMID: 17692154
• Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

  Bruckert E, Giral P, Tellier P. Bruckert E, et al. Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24. Circulation. 2003. PMID: 12835406 Review. No abstract available.